Pliant Therapeutics, Inc.
PLRX
$1.38
-$0.09-6.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.94% | 13.90% | -3.42% | -18.95% | -14.22% |
| Total Depreciation and Amortization | -2.18% | -13.91% | -14.47% | 21.25% | 10.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.22% | -8.55% | -8.05% | 1.83% | -23.41% |
| Change in Net Operating Assets | 48.25% | -157.41% | 932.30% | -136.17% | 677.18% |
| Cash from Operations | -2.52% | -47.68% | 28.75% | -49.64% | -20.59% |
| Capital Expenditure | -25.36% | 76.67% | 28.38% | 16.15% | -2,345.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.35% | 23.50% | 166.51% | -80.42% | 90.85% |
| Cash from Investing | 76.62% | 26.40% | 189.29% | -82.03% | 86.54% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 393.07% | -81.40% | -20.61% | -63.60% | 709.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 388.24% | -81.22% | -20.61% | -96.86% | 9,848.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 346.18% | -994.55% | 97.73% | -166.41% | 625.53% |